Concepedia

Corinne Anklin

CA

4

Publications

403

Citations

4

H-Index

2009

Active since

Affiliations

Santhera Pharmaceuticals (Switzerland)(Current)

University of Zurich

Corinne Anklin is an author at Santhera Pharmaceuticals (Switzerland) specializing in medicine, oxidative stress, and pharmacology.

Top concepts

Publications per year

2009–2012

4

Publications

4

NQO1-Dependent Redox Cycling of Idebenone: Effects on Cellular Redox Potential and Energy Levels

Roman H. Haefeli, Michael A. Erb, Anja C. Gemperli et al. · PLoS ONE · 2011 · 187 citations · Full text

, , +21

Idebenone Protects against Retinal Damage and Loss of Vision in a Mouse Model of Leber’s Hereditary Optic Neuropathy

Fabrice D. Heitz, Michael A. Erb, Corinne Anklin et al. · PLoS ONE · 2012 · 110 citations · Full text

, , +19

The orally active melanocortin-4 receptor antagonist BL-6020/979: a promising candidate for the treatment of cancer cachexia

Robert Dallmann, Philipp Weyermann, Corinne Anklin et al. · Journal of Cachexia Sarcopenia and Muscle · 2011 · 55 citations · Full text

Orally Available Selective Melanocortin-4 Receptor Antagonists Stimulate Food Intake and Reduce Cancer-Induced Cachexia in Mice

Philipp Weyermann, Robert Dallmann, Josef P. Magyar et al. · PLoS ONE · 2009 · 51 citations · Full text

Rows per page

1–4 of 4